Compare VOR & OTGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VOR | OTGA |
|---|---|---|
| Founded | 2015 | 2025 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 345.1M | 295.1M |
| IPO Year | 2021 | 2025 |
| Metric | VOR | OTGA |
|---|---|---|
| Price | $12.06 | $10.07 |
| Analyst Decision | Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $64.78 | N/A |
| AVG Volume (30 Days) | ★ 956.5K | 51.4K |
| Earning Date | 03-19-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.62 | $9.97 |
| 52 Week High | $65.80 | $10.12 |
| Indicator | VOR | OTGA |
|---|---|---|
| Relative Strength Index (RSI) | 41.17 | 63.16 |
| Support Level | $13.00 | $10.07 |
| Resistance Level | $15.00 | $10.10 |
| Average True Range (ATR) | 1.41 | 0.02 |
| MACD | -0.45 | 0.00 |
| Stochastic Oscillator | 8.68 | 57.14 |
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.
OTG Acquisition Corp I is a newly organized blank check company.